We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appeals Court Rules Against Biogen in Tecfidera Patent Dispute
Appeals Court Rules Against Biogen in Tecfidera Patent Dispute
A federal appeals court has ruled that Banner Life Sciences may make and market its version of Biogen’s blockbuster multiple sclerosis drug, Tecfidera (dimethyl fumarate).